why choose us

First received: December 23, 2022

Clinical Trial: The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Antineutrophil Cytoplasmic Antibody Associated Vasculitis

Study Type: INTERVENTIONAL


Official Title: An Open-label, Single-ascending Dose, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of STSA-1002 Subcutaneous Injection in Healthy Subjects

Brief Summary: An Open-label, Single-ascending dose, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of STSA-1002 Subcutaneous Injection in Healthy Subjects

Read more